AI Insight
Atherosclerotic cardiovascular disease remains the leading cause of premature death globally, but current mortality statistics, research publications, and clinical guidelines have historically concentrated on cardiac and cerebrovascular events while largely overlooking peripheral arterial disease. Lower extremity peripheral arterial disease is increasing in prevalence and placing growing strain on healthcare systems worldwide. This focus on heart and brain-related complications may create an incomplete understanding of vascular risk across the full spectrum of atherosclerotic disease.
Why it matters
Recognition of peripheral arterial disease as a major component of atherosclerotic disease burden could reshape clinical priorities, research funding allocation, and preventive care strategies. Improved attention to lower extremity vascular disease may lead to better screening protocols, earlier interventions, and more comprehensive patient care for individuals at risk of atherosclerotic complications.
Understand the Science
Atherosclerotic cardiovascular disease is the primary driver of premature death in global populations in recent decades. Mortality statistics, most publications, and guidelines in the atherosclerotic cardiovascular disease field have traditionally focused on cardiac and cerebrovascular adverse events and causes of death. However, given the increasing prevalence of lower extremity peripheral arterial disease and its expanding burden on global health systems, such an emphasis might represent a skewed perception of vascular risk within the broader atherosclerotic spectrum.
Source: [Series] Understanding peripheral arterial disease in the current era